B-type natriuretic peptide in the evaluation of cardiac function

Valle, Adriana Polachini do; Villas Boas, Paulo José Fortes; Vidal, Edison Iglesias de Oliveira; Fukushima, Fernanda Bono.
J. bras. patol. med. lab ; 49(4): 241-246, Aug. 2013. tab
Artículo en Inglés | LILACS | ID: lil-697097

Documentos relacionados

  1. NT-ProBNP: marcador biológico útil para monitorización del estado clínico y como factor pronóstico en pacientes ambulatorios portadores de insuficiencia cardíaca sistólica
  2. Metanálise de esporotricose felina: um destaque para sua ocorrência no Brasil
  3. Worsening Renal Function and Congestion in Patients with Acute Heart Failure: A Study with Bioelectrical Impedance Vector Analysis (BIVA) and Neutrophil Gelatinase-Associated Lipocalin (NGAL).
  4. A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at risk of heart failure.
  5. Time-Dependent Changes in N-Terminal Pro-Brain Natriuretic Peptide and B-Type Natriuretic Peptide Ratio During Hospitalization for Acute Heart Failure.
  6. An Hypothesis: Disproportion Between Cardiac Troponin and B-Type Natriuretic Peptide Levels-A High Risk and Poor Prognostic Biomarker in Patients With Fulminant Myocarditis?
  7. Use of Preoperative Natriuretic Peptide in Predicting Mortality After Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis.
  8. Prognostic Value of Plasma NT-proBNP levels in Hospitalized Patients Older than 80 Years of Age in a Hospital in Beijing, China.
  9. Global longitudinal strain and plasma biomarkers for prognosis in heart failure complicated by diabetes: a prospective observational study.
  10. Potential utility of B-type natriuretic peptides in secondary prevention following percutaneous coronary intervention in remote communities of Western Australia.